In clinical studies, users of GL-1 8--1 & achieved impressive results, with some losing as much as 68 lbs of stubborn fat in just one week
The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication
Dulaglutide and Exenatide qw did not require any titration, and they were started at 1.5 and 2 mg from the first administration with global exposure to the specific GLP-1RA total dose of 28 weeks in both the AWARD-9 and DURATION-7
To arrive at putative mechanisms, below we discuss 5-HT and carnitine, along with their possible links to fatigue
The team at Semaglutide Medics is here to give you clear instructions so you always feel safe and sure of what you are doing